162 related articles for article (PubMed ID: 29163089)
21. Olfactory bulb atrophy and caspase activation observed in the BACHD rat models of Huntington disease.
Lessard-Beaudoin M; Yu-Taeger L; Laroche M; Singer E; Riess O; Nguyen HHP; Graham RK
Neurobiol Dis; 2019 May; 125():219-231. PubMed ID: 30738141
[TBL] [Abstract][Full Text] [Related]
22. 'Super-Enrichment' Reveals Dose-Dependent Therapeutic Effects of Environmental Stimulation in a Transgenic Mouse Model of Huntington's Disease.
Mazarakis NK; Mo C; Renoir T; van Dellen A; Deacon R; Blakemore C; Hannan AJ
J Huntingtons Dis; 2014; 3(3):299-309. PubMed ID: 25300333
[TBL] [Abstract][Full Text] [Related]
23. A Longitudinal Motor Characterisation of the HdhQ111 Mouse Model of Huntington's Disease.
Yhnell E; Dunnett SB; Brooks SP
J Huntingtons Dis; 2016 May; 5(2):149-61. PubMed ID: 27258586
[TBL] [Abstract][Full Text] [Related]
24. The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task- and protocol-dependent: influence of non-motor factors on locomotor function.
Pallier PN; Drew CJ; Morton AJ
Brain Res Bull; 2009 Mar; 78(6):347-55. PubMed ID: 19010400
[TBL] [Abstract][Full Text] [Related]
25. Changes in structure and function of diaphragm neuromuscular junctions from BACHD mouse model for Huntington's disease.
de Aragão BC; Rodrigues HA; Valadão PA; Camargo W; Naves LA; Ribeiro FM; Guatimosim C
Neurochem Int; 2016 Feb; 93():64-72. PubMed ID: 26796203
[TBL] [Abstract][Full Text] [Related]
26. Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease.
Spampanato J; Gu X; Yang XW; Mody I
Neuroscience; 2008 Dec; 157(3):606-20. PubMed ID: 18854207
[TBL] [Abstract][Full Text] [Related]
27. Early deficits in declarative and procedural memory dependent behavioral function in a transgenic rat model of Huntington's disease.
Kirch RD; Meyer PT; Geisler S; Braun F; Gehrig S; Langen KJ; von Hörsten S; Nikkhah G; Cassel JC; Döbrössy MD
Behav Brain Res; 2013 Feb; 239():15-26. PubMed ID: 23137697
[TBL] [Abstract][Full Text] [Related]
28. Dietary ketosis improves circadian dysfunction as well as motor symptoms in the BACHD mouse model of Huntington's disease.
Whittaker DS; Tamai TK; Bains RS; Villanueva SAM; Luk SHC; Dell'Angelica D; Block GD; Ghiani CA; Colwell CS
Front Nutr; 2022; 9():1034743. PubMed ID: 36407529
[TBL] [Abstract][Full Text] [Related]
29. Early cognitive dysfunction in the HD 51 CAG transgenic rat model of Huntington's disease.
Fink KD; Rossignol J; Crane AT; Davis KK; Bavar AM; Dekorver NW; Lowrance SA; Reilly MP; Sandstrom MI; von Hörsten S; Lescaudron L; Dunbar GL
Behav Neurosci; 2012 Jun; 126(3):479-87. PubMed ID: 22642889
[TBL] [Abstract][Full Text] [Related]
30. Dysregulation of gene expression in the striatum of BACHD rats expressing full-length mutant huntingtin and associated abnormalities on molecular and protein levels.
Yu-Taeger L; Bonin M; Stricker-Shaver J; Riess O; Nguyen HHP
Neuropharmacology; 2017 May; 117():260-272. PubMed ID: 28153533
[TBL] [Abstract][Full Text] [Related]
31. Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice.
Pouladi MA; Stanek LM; Xie Y; Franciosi S; Southwell AL; Deng Y; Butland S; Zhang W; Cheng SH; Shihabuddin LS; Hayden MR
Hum Mol Genet; 2012 May; 21(10):2219-32. PubMed ID: 22328089
[TBL] [Abstract][Full Text] [Related]
32. Differential Cellular Balance of Olfactory and Vomeronasal Epithelia in a Transgenic BACHD Rat Model of Huntington's Disease.
Krysewski LM; Power Guerra N; Glatzel A; Holzmann C; Antipova V; Schmitt O; Yu-Taeger L; Nguyen HP; Wree A; Witt M
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886975
[No Abstract] [Full Text] [Related]
33. Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
Clemens LE; Weber JJ; Wlodkowski TT; Yu-Taeger L; Michaud M; Calaminus C; Eckert SH; Gaca J; Weiss A; Magg JC; Jansson EK; Eckert GP; Pichler BJ; Bordet T; Pruss RM; Riess O; Nguyen HP
Brain; 2015 Dec; 138(Pt 12):3632-53. PubMed ID: 26490331
[TBL] [Abstract][Full Text] [Related]
34. The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.
Doria JG; de Souza JM; Andrade JN; Rodrigues HA; Guimaraes IM; Carvalho TG; Guatimosim C; Dobransky T; Ribeiro FM
Neurobiol Dis; 2015 Jan; 73():163-73. PubMed ID: 25160573
[TBL] [Abstract][Full Text] [Related]
35. Gene-dosage- and sex-dependent differences in the prodromal-Like phase of the F344tgHD rat model for Huntington disease.
Ratz-Wirsching V; Habermeyer J; Moceri S; Harrer J; Schmitz C; von Hörsten S
Front Neurosci; 2024; 18():1354977. PubMed ID: 38384482
[TBL] [Abstract][Full Text] [Related]
36. Early Alterations in Operant Performance and Prominent Huntingtin Aggregation in a Congenic F344 Rat Line of the Classical CAG
Plank AC; Canneva F; Raber KA; Urbach YK; Dobner J; Puchades M; Bjaalie JG; Gillmann C; Bäuerle T; Riess O; Nguyen HHP; von Hörsten S
Front Neurosci; 2018; 12():11. PubMed ID: 29422836
[TBL] [Abstract][Full Text] [Related]
37. Behavioral phenotyping of minipigs transgenic for the Huntington gene.
Schramke S; Schuldenzucker V; Schubert R; Frank F; Wirsig M; Ott S; Motlik J; Fels M; Kemper N; Hölzner E; Reilmann R
J Neurosci Methods; 2016 May; 265():34-45. PubMed ID: 26688470
[TBL] [Abstract][Full Text] [Related]
38. Automated home cage assessment shows behavioral changes in a transgenic mouse model of spinocerebellar ataxia type 17.
Portal E; Riess O; Nguyen HP
Behav Brain Res; 2013 Aug; 250():157-65. PubMed ID: 23665119
[TBL] [Abstract][Full Text] [Related]
39. Home-cage anxiety levels in a transgenic rat model for Spinocerebellar ataxia type 17 measured by an approach-avoidance task: The light spot test.
Kyriakou EI; Nguyen HP; Homberg JR; Van der Harst JE
J Neurosci Methods; 2018 Apr; 300():48-58. PubMed ID: 28823507
[TBL] [Abstract][Full Text] [Related]
40. High-Throughput Automated Phenotyping of Two Genetic Mouse Models of Huntington's Disease.
Balci F; Oakeshott S; Shamy JL; El-Khodor BF; Filippov I; Mushlin R; Port R; Connor D; Paintdakhi A; Menalled L; Ramboz S; Howland D; Kwak S; Brunner D
PLoS Curr; 2013 Jul; 5():. PubMed ID: 23863947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
